The global Nuclear Medicine Radioisotopes market was valued at US$ 3457.9 million in 2023 and is anticipated to reach US$ 4486.1 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

Nuclear Medicine Radioisotopes Market

Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine Radioisotopes.

Report Scope

The Nuclear Medicine Radioisotopes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nuclear Medicine Radioisotopes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nuclear Medicine Radioisotopes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nuclear Medicine Radioisotopes Market Report

Report Metric	Details
Report Name	Nuclear Medicine Radioisotopes Market
Accounted market size in 2023	US$ 3457.9 million
Forecasted market size in 2030	US$ 4486.1 million
CAGR	3.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Thallium-201 (Tl-201) Iodine (I-123) Fluorine-18 Rubidium-82 (Rb-82) Other
Segment by Application	Tumor Heart Disease Lymphoma Thyroid Gland Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Agfa-Gevaert Group, Braco, Cardiarc, Cardinal Health, CMR Naviscan (Gamma Medica Inc.), Curium, Digirad, GE Healthcare, Nordion (Canada), NTP Radioisotopes SOC, Positron, Segami, Siemens Healthcare
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nuclear Medicine Radioisotopes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nuclear Medicine Radioisotopes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Nuclear Medicine Radioisotopes Market growing?

Ans: The Nuclear Medicine Radioisotopes Market witnessing a CAGR of 3.3% during the forecast period 2024-2030.

What is the Nuclear Medicine Radioisotopes Market size in 2030?

Ans: The Nuclear Medicine Radioisotopes Market size in 2030 will be US$ 4486.1 million.

Who are the main players in the Nuclear Medicine Radioisotopes Market report?

Ans: The main players in the Nuclear Medicine Radioisotopes Market are Agfa-Gevaert Group, Braco, Cardiarc, Cardinal Health, CMR Naviscan (Gamma Medica Inc.), Curium, Digirad, GE Healthcare, Nordion (Canada), NTP Radioisotopes SOC, Positron, Segami, Siemens Healthcare

What are the Application segmentation covered in the Nuclear Medicine Radioisotopes Market report?

Ans: The Applications covered in the Nuclear Medicine Radioisotopes Market report are Tumor, Heart Disease, Lymphoma, Thyroid Gland, Other

What are the Type segmentation covered in the Nuclear Medicine Radioisotopes Market report?

Ans: The Types covered in the Nuclear Medicine Radioisotopes Market report are Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Other

1 Nuclear Medicine Radioisotopes Market Overview

1.1 Product Overview and Scope of Nuclear Medicine Radioisotopes

1.2 Nuclear Medicine Radioisotopes Segment by Type

1.2.1 Global Nuclear Medicine Radioisotopes Market Value Comparison by Type (2024-2030)

1.2.2 Thallium-201 (Tl-201)

1.2.3 Iodine (I-123)

1.2.4 Fluorine-18

1.2.5 Rubidium-82 (Rb-82)

1.2.6 Other

1.3 Nuclear Medicine Radioisotopes Segment by Application

1.3.1 Global Nuclear Medicine Radioisotopes Market Value by Application: (2024-2030)

1.3.2 Tumor

1.3.3 Heart Disease

1.3.4 Lymphoma

1.3.5 Thyroid Gland

1.3.6 Other

1.4 Global Nuclear Medicine Radioisotopes Market Size Estimates and Forecasts

1.4.1 Global Nuclear Medicine Radioisotopes Revenue 2019-2030

1.4.2 Global Nuclear Medicine Radioisotopes Sales 2019-2030

1.4.3 Global Nuclear Medicine Radioisotopes Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Nuclear Medicine Radioisotopes Market Competition by Manufacturers

2.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturers (2019-2024)

2.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Nuclear Medicine Radioisotopes Average Price by Manufacturers (2019-2024)

2.4 Global Nuclear Medicine Radioisotopes Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Nuclear Medicine Radioisotopes, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nuclear Medicine Radioisotopes, Product Type & Application

2.7 Nuclear Medicine Radioisotopes Market Competitive Situation and Trends

2.7.1 Nuclear Medicine Radioisotopes Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Nuclear Medicine Radioisotopes Players Market Share by Revenue

2.7.3 Global Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nuclear Medicine Radioisotopes Retrospective Market Scenario by Region

3.1 Global Nuclear Medicine Radioisotopes Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Nuclear Medicine Radioisotopes Global Nuclear Medicine Radioisotopes Sales by Region: 2019-2030

3.2.1 Global Nuclear Medicine Radioisotopes Sales by Region: 2019-2024

3.2.2 Global Nuclear Medicine Radioisotopes Sales by Region: 2025-2030

3.3 Global Nuclear Medicine Radioisotopes Global Nuclear Medicine Radioisotopes Revenue by Region: 2019-2030

3.3.1 Global Nuclear Medicine Radioisotopes Revenue by Region: 2019-2024

3.3.2 Global Nuclear Medicine Radioisotopes Revenue by Region: 2025-2030

3.4 North America Nuclear Medicine Radioisotopes Market Facts & Figures by Country

3.4.1 North America Nuclear Medicine Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Nuclear Medicine Radioisotopes Sales by Country (2019-2030)

3.4.3 North America Nuclear Medicine Radioisotopes Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Nuclear Medicine Radioisotopes Market Facts & Figures by Country

3.5.1 Europe Nuclear Medicine Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Nuclear Medicine Radioisotopes Sales by Country (2019-2030)

3.5.3 Europe Nuclear Medicine Radioisotopes Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nuclear Medicine Radioisotopes Market Facts & Figures by Country

3.6.1 Asia Pacific Nuclear Medicine Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Nuclear Medicine Radioisotopes Sales by Country (2019-2030)

3.6.3 Asia Pacific Nuclear Medicine Radioisotopes Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Nuclear Medicine Radioisotopes Market Facts & Figures by Country

3.7.1 Latin America Nuclear Medicine Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Nuclear Medicine Radioisotopes Sales by Country (2019-2030)

3.7.3 Latin America Nuclear Medicine Radioisotopes Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Nuclear Medicine Radioisotopes Market Facts & Figures by Country

3.8.1 Middle East and Africa Nuclear Medicine Radioisotopes Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Nuclear Medicine Radioisotopes Sales by Country (2019-2030)

3.8.3 Middle East and Africa Nuclear Medicine Radioisotopes Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Nuclear Medicine Radioisotopes Sales by Type (2019-2030)

4.1.1 Global Nuclear Medicine Radioisotopes Sales by Type (2019-2024)

4.1.2 Global Nuclear Medicine Radioisotopes Sales by Type (2025-2030)

4.1.3 Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2030)

4.2 Global Nuclear Medicine Radioisotopes Revenue by Type (2019-2030)

4.2.1 Global Nuclear Medicine Radioisotopes Revenue by Type (2019-2024)

4.2.2 Global Nuclear Medicine Radioisotopes Revenue by Type (2025-2030)

4.2.3 Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2019-2030)

4.3 Global Nuclear Medicine Radioisotopes Price by Type (2019-2030)

5 Segment by Application

5.1 Global Nuclear Medicine Radioisotopes Sales by Application (2019-2030)

5.1.1 Global Nuclear Medicine Radioisotopes Sales by Application (2019-2024)

5.1.2 Global Nuclear Medicine Radioisotopes Sales by Application (2025-2030)

5.1.3 Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2030)

5.2 Global Nuclear Medicine Radioisotopes Revenue by Application (2019-2030)

5.2.1 Global Nuclear Medicine Radioisotopes Revenue by Application (2019-2024)

5.2.2 Global Nuclear Medicine Radioisotopes Revenue by Application (2025-2030)

5.2.3 Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2019-2030)

5.3 Global Nuclear Medicine Radioisotopes Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Agfa-Gevaert Group

6.1.1 Agfa-Gevaert Group Corporation Information

6.1.2 Agfa-Gevaert Group Description and Business Overview

6.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Portfolio

6.1.5 Agfa-Gevaert Group Recent Developments/Updates

6.2 Braco

6.2.1 Braco Corporation Information

6.2.2 Braco Description and Business Overview

6.2.3 Braco Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Braco Nuclear Medicine Radioisotopes Product Portfolio

6.2.5 Braco Recent Developments/Updates

6.3 Cardiarc

6.3.1 Cardiarc Corporation Information

6.3.2 Cardiarc Description and Business Overview

6.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Cardiarc Nuclear Medicine Radioisotopes Product Portfolio

6.3.5 Cardiarc Recent Developments/Updates

6.4 Cardinal Health

6.4.1 Cardinal Health Corporation Information

6.4.2 Cardinal Health Description and Business Overview

6.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Cardinal Health Nuclear Medicine Radioisotopes Product Portfolio

6.4.5 Cardinal Health Recent Developments/Updates

6.5 CMR Naviscan (Gamma Medica Inc.)

6.5.1 CMR Naviscan (Gamma Medica Inc.) Corporation Information

6.5.2 CMR Naviscan (Gamma Medica Inc.) Description and Business Overview

6.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.5.4 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Portfolio

6.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Developments/Updates

6.6 Curium

6.6.1 Curium Corporation Information

6.6.2 Curium Description and Business Overview

6.6.3 Curium Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Curium Nuclear Medicine Radioisotopes Product Portfolio

6.6.5 Curium Recent Developments/Updates

6.7 Digirad

6.6.1 Digirad Corporation Information

6.6.2 Digirad Description and Business Overview

6.6.3 Digirad Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Digirad Nuclear Medicine Radioisotopes Product Portfolio

6.7.5 Digirad Recent Developments/Updates

6.8 GE Healthcare

6.8.1 GE Healthcare Corporation Information

6.8.2 GE Healthcare Description and Business Overview

6.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.8.4 GE Healthcare Nuclear Medicine Radioisotopes Product Portfolio

6.8.5 GE Healthcare Recent Developments/Updates

6.9 Nordion (Canada)

6.9.1 Nordion (Canada) Corporation Information

6.9.2 Nordion (Canada) Description and Business Overview

6.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Nordion (Canada) Nuclear Medicine Radioisotopes Product Portfolio

6.9.5 Nordion (Canada) Recent Developments/Updates

6.10 NTP Radioisotopes SOC

6.10.1 NTP Radioisotopes SOC Corporation Information

6.10.2 NTP Radioisotopes SOC Description and Business Overview

6.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.10.4 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Portfolio

6.10.5 NTP Radioisotopes SOC Recent Developments/Updates

6.11 Positron

6.11.1 Positron Corporation Information

6.11.2 Positron Nuclear Medicine Radioisotopes Description and Business Overview

6.11.3 Positron Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Positron Nuclear Medicine Radioisotopes Product Portfolio

6.11.5 Positron Recent Developments/Updates

6.12 Segami

6.12.1 Segami Corporation Information

6.12.2 Segami Nuclear Medicine Radioisotopes Description and Business Overview

6.12.3 Segami Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Segami Nuclear Medicine Radioisotopes Product Portfolio

6.12.5 Segami Recent Developments/Updates

6.13 Siemens Healthcare

6.13.1 Siemens Healthcare Corporation Information

6.13.2 Siemens Healthcare Nuclear Medicine Radioisotopes Description and Business Overview

6.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Siemens Healthcare Nuclear Medicine Radioisotopes Product Portfolio

6.13.5 Siemens Healthcare Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Nuclear Medicine Radioisotopes Industry Chain Analysis

7.2 Nuclear Medicine Radioisotopes Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nuclear Medicine Radioisotopes Production Mode & Process

7.4 Nuclear Medicine Radioisotopes Sales and Marketing

7.4.1 Nuclear Medicine Radioisotopes Sales Channels

7.4.2 Nuclear Medicine Radioisotopes Distributors

7.5 Nuclear Medicine Radioisotopes Customers

8 Nuclear Medicine Radioisotopes Market Dynamics

8.1 Nuclear Medicine Radioisotopes Industry Trends

8.2 Nuclear Medicine Radioisotopes Market Drivers

8.3 Nuclear Medicine Radioisotopes Market Challenges

8.4 Nuclear Medicine Radioisotopes Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

CMR Naviscan (Gamma Medica Inc.)

NTP Radioisotopes SOC

Positron

Segami

Siemens Healthcare

List of Tables

Table 1. Global Nuclear Medicine Radioisotopes Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Nuclear Medicine Radioisotopes Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Nuclear Medicine Radioisotopes Market Competitive Situation by Manufacturers in 2023

Table 4. Global Nuclear Medicine Radioisotopes Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Nuclear Medicine Radioisotopes Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Nuclear Medicine Radioisotopes, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Nuclear Medicine Radioisotopes, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Nuclear Medicine Radioisotopes, Product Type & Application

Table 12. Global Key Manufacturers of Nuclear Medicine Radioisotopes, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Nuclear Medicine Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Radioisotopes as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Nuclear Medicine Radioisotopes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Nuclear Medicine Radioisotopes Sales by Region (2019-2024) & (K Units)

Table 18. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2019-2024)

Table 19. Global Nuclear Medicine Radioisotopes Sales by Region (2025-2030) & (K Units)

Table 20. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2025-2030)

Table 21. Global Nuclear Medicine Radioisotopes Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2019-2024)

Table 23. Global Nuclear Medicine Radioisotopes Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2025-2030)

Table 25. North America Nuclear Medicine Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 27. North America Nuclear Medicine Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 28. North America Nuclear Medicine Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Nuclear Medicine Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Nuclear Medicine Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 32. Europe Nuclear Medicine Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 33. Europe Nuclear Medicine Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Nuclear Medicine Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Nuclear Medicine Radioisotopes Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Nuclear Medicine Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Nuclear Medicine Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Nuclear Medicine Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Nuclear Medicine Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Nuclear Medicine Radioisotopes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Nuclear Medicine Radioisotopes Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Nuclear Medicine Radioisotopes Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Nuclear Medicine Radioisotopes Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Nuclear Medicine Radioisotopes Sales (K Units) by Type (2019-2024)

Table 51. Global Nuclear Medicine Radioisotopes Sales (K Units) by Type (2025-2030)

Table 52. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2019-2024)

Table 53. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2025-2030)

Table 54. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2019-2024)

Table 57. Global Nuclear Medicine Radioisotopes Revenue Market Share by Type (2025-2030)

Table 58. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Type (2019-2024)

Table 59. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Type (2025-2030)

Table 60. Global Nuclear Medicine Radioisotopes Sales (K Units) by Application (2019-2024)

Table 61. Global Nuclear Medicine Radioisotopes Sales (K Units) by Application (2025-2030)

Table 62. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2019-2024)

Table 63. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2025-2030)

Table 64. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2019-2024)

Table 67. Global Nuclear Medicine Radioisotopes Revenue Market Share by Application (2025-2030)

Table 68. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Application (2019-2024)

Table 69. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Application (2025-2030)

Table 70. Agfa-Gevaert Group Corporation Information

Table 71. Agfa-Gevaert Group Description and Business Overview

Table 72. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product

Table 74. Agfa-Gevaert Group Recent Developments/Updates

Table 75. Braco Corporation Information

Table 76. Braco Description and Business Overview

Table 77. Braco Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Braco Nuclear Medicine Radioisotopes Product

Table 79. Braco Recent Developments/Updates

Table 80. Cardiarc Corporation Information

Table 81. Cardiarc Description and Business Overview

Table 82. Cardiarc Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Cardiarc Nuclear Medicine Radioisotopes Product

Table 84. Cardiarc Recent Developments/Updates

Table 85. Cardinal Health Corporation Information

Table 86. Cardinal Health Description and Business Overview

Table 87. Cardinal Health Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Cardinal Health Nuclear Medicine Radioisotopes Product

Table 89. Cardinal Health Recent Developments/Updates

Table 90. CMR Naviscan (Gamma Medica Inc.) Corporation Information

Table 91. CMR Naviscan (Gamma Medica Inc.) Description and Business Overview

Table 92. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product

Table 94. CMR Naviscan (Gamma Medica Inc.) Recent Developments/Updates

Table 95. Curium Corporation Information

Table 96. Curium Description and Business Overview

Table 97. Curium Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Curium Nuclear Medicine Radioisotopes Product

Table 99. Curium Recent Developments/Updates

Table 100. Digirad Corporation Information

Table 101. Digirad Description and Business Overview

Table 102. Digirad Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Digirad Nuclear Medicine Radioisotopes Product

Table 104. Digirad Recent Developments/Updates

Table 105. GE Healthcare Corporation Information

Table 106. GE Healthcare Description and Business Overview

Table 107. GE Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. GE Healthcare Nuclear Medicine Radioisotopes Product

Table 109. GE Healthcare Recent Developments/Updates

Table 110. Nordion (Canada) Corporation Information

Table 111. Nordion (Canada) Description and Business Overview

Table 112. Nordion (Canada) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Nordion (Canada) Nuclear Medicine Radioisotopes Product

Table 114. Nordion (Canada) Recent Developments/Updates

Table 115. NTP Radioisotopes SOC Corporation Information

Table 116. NTP Radioisotopes SOC Description and Business Overview

Table 117. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product

Table 119. NTP Radioisotopes SOC Recent Developments/Updates

Table 120. Positron Corporation Information

Table 121. Positron Description and Business Overview

Table 122. Positron Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Positron Nuclear Medicine Radioisotopes Product

Table 124. Positron Recent Developments/Updates

Table 125. Segami Corporation Information

Table 126. Segami Description and Business Overview

Table 127. Segami Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Segami Nuclear Medicine Radioisotopes Product

Table 129. Segami Recent Developments/Updates

Table 130. Siemens Healthcare Corporation Information

Table 131. Siemens Healthcare Description and Business Overview

Table 132. Siemens Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Siemens Healthcare Nuclear Medicine Radioisotopes Product

Table 134. Siemens Healthcare Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Nuclear Medicine Radioisotopes Distributors List

Table 138. Nuclear Medicine Radioisotopes Customers List

Table 139. Nuclear Medicine Radioisotopes Market Trends

Table 140. Nuclear Medicine Radioisotopes Market Drivers

Table 141. Nuclear Medicine Radioisotopes Market Challenges

Table 142. Nuclear Medicine Radioisotopes Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Nuclear Medicine Radioisotopes

Figure 2. Global Nuclear Medicine Radioisotopes Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Nuclear Medicine Radioisotopes Market Share by Type in 2023 & 2030

Figure 4. Thallium-201 (Tl-201) Product Picture

Figure 5. Iodine (I-123) Product Picture

Figure 6. Fluorine-18 Product Picture

Figure 7. Rubidium-82 (Rb-82) Product Picture

Figure 8. Other Product Picture

Figure 9. Global Nuclear Medicine Radioisotopes Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Nuclear Medicine Radioisotopes Market Share by Application in 2023 & 2030

Figure 11. Tumor

Figure 12. Heart Disease

Figure 13. Lymphoma

Figure 14. Thyroid Gland

Figure 15. Other

Figure 16. Global Nuclear Medicine Radioisotopes Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Nuclear Medicine Radioisotopes Market Size (2019-2030) & (US$ Million)

Figure 18. Global Nuclear Medicine Radioisotopes Sales (2019-2030) & (K Units)

Figure 19. Global Nuclear Medicine Radioisotopes Average Price (USD/Unit) & (2019-2030)

Figure 20. Nuclear Medicine Radioisotopes Report Years Considered

Figure 21. Nuclear Medicine Radioisotopes Sales Share by Manufacturers in 2023

Figure 22. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers in 2023

Figure 23. The Global 5 and 10 Largest Nuclear Medicine Radioisotopes Players: Market Share by Revenue in 2023

Figure 24. Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 25. Global Nuclear Medicine Radioisotopes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 26. North America Nuclear Medicine Radioisotopes Sales Market Share by Country (2019-2030)

Figure 27. North America Nuclear Medicine Radioisotopes Revenue Market Share by Country (2019-2030)

Figure 28. U.S. Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Canada Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Europe Nuclear Medicine Radioisotopes Sales Market Share by Country (2019-2030)

Figure 31. Europe Nuclear Medicine Radioisotopes Revenue Market Share by Country (2019-2030)

Figure 32. Germany Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. France Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. U.K. Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Italy Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Russia Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Asia Pacific Nuclear Medicine Radioisotopes Sales Market Share by Region (2019-2030)

Figure 38. Asia Pacific Nuclear Medicine Radioisotopes Revenue Market Share by Region (2019-2030)

Figure 39. China Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Japan Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. South Korea Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. India Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Australia Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Taiwan Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Indonesia Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Thailand Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Malaysia Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Philippines Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Latin America Nuclear Medicine Radioisotopes Sales Market Share by Country (2019-2030)

Figure 50. Latin America Nuclear Medicine Radioisotopes Revenue Market Share by Country (2019-2030)

Figure 51. Mexico Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Brazil Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Argentina Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Middle East & Africa Nuclear Medicine Radioisotopes Sales Market Share by Country (2019-2030)

Figure 55. Middle East & Africa Nuclear Medicine Radioisotopes Revenue Market Share by Country (2019-2030)

Figure 56. Turkey Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. U.A.E Nuclear Medicine Radioisotopes Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. Global Sales Market Share of Nuclear Medicine Radioisotopes by Type (2019-2030)

Figure 60. Global Revenue Market Share of Nuclear Medicine Radioisotopes by Type (2019-2030)

Figure 61. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Type (2019-2030)

Figure 62. Global Sales Market Share of Nuclear Medicine Radioisotopes by Application (2019-2030)

Figure 63. Global Revenue Market Share of Nuclear Medicine Radioisotopes by Application (2019-2030)

Figure 64. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Application (2019-2030)

Figure 65. Nuclear Medicine Radioisotopes Value Chain

Figure 66. Nuclear Medicine Radioisotopes Production Process

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Distributors Profiles

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Probe Cover Kit with Sterile Gel Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36A15620

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Digital Dental 3D Intraoral Scanner Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-16A15913

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Bench-Top Fundus Camera Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-8B15902

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Chromic Gut Sutures Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12H15739

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions